STAT

Congress revives ban on altering the DNA of human embryos used for pregnancies

Congress has revived a ban on altering the DNA of human embryos used for pregnancies, despite the objections of some scientists.
Rep. Robert Aderholt (R-Ala.)

A House committee on Tuesday restored to pending legislation a ban on altering the genomes of human embryos intended for pregnancies, despite calls from some scientists to lift the ban and allow the Food and Drug Administration to review applications for new technologies.

Lifting the prohibition could have opened the door to clinical trials of babies being made with genetic material from three people or with genomes that had been changed in ways that would be

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks